Literature DB >> 21763681

Relevance of periostin splice variants in renal cell carcinoma.

Laura Morra1, Markus Rechsteiner, Silvia Casagrande, Van Duc Luu, Roger Santimaria, Pierre A Diener, Tullio Sulser, Glen Kristiansen, Peter Schraml, Holger Moch, Alex Soltermann.   

Abstract

The extracellular matrix N-glycoprotein periostin is thought to enhance tumor invasion. In this study, the expression patterns of periostin and its splice isoforms were investigated in renal cell carcinoma (RCC). Periostin mRNA expression patterns were characterized in 30 fresh-frozen RCCs in normal fetal and adult renal tissues by both isoform-specific and nonspecific RT-PCR and by gene expression array analysis. Its protein expression was analyzed by immunohistochemistry, using tissue microarrays with tissue from 1007 RCC patients. Periostin mRNA in RCC was increased, as observed in both RT-PCR and gene microarray analyses, with significantly higher expression in the clear cell than in the papillary subtype. Four of eight periostin isoforms, identified in fetal kidney by direct sequencing, have not been described to date. Three isoforms could be detected in both RCC and matched non-neoplastic tissue, and one of them was expressed more frequently in RCC. Periostin protein was detected in both mesenchymal cells of the tumor stroma and epithelial tumor cells. Greater amounts of periostin in tumor epithelia correlated with the presence of sarcomatoid differentiation, higher tumor stage, lymph node metastases, and poor overall survival in the clear cell subtype. In conclusion, periostin expression in tumor epithelia may contribute to sarcomatoid differentiation and more aggressive behavior of RCC. The presence of a tumor-associated periostin isoform suggests splice-specific regulation in RCC tissue.
Copyright © 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21763681      PMCID: PMC3157167          DOI: 10.1016/j.ajpath.2011.05.035

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  50 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.

Authors:  H Moch; T Gasser; M B Amin; J Torhorst; G Sauter; M J Mihatsch
Journal:  Cancer       Date:  2000-08-01       Impact factor: 6.860

3.  Gene expression of periostin in the early stage of fracture healing detected by cDNA microarray analysis.

Authors:  Tetsuro Nakazawa; Arata Nakajima; Naohiko Seki; Akihiko Okawa; Masaki Kato; Hidesige Moriya; Norio Amizuka; Thomas A Einhorn; Masashi Yamazaki
Journal:  J Orthop Res       Date:  2004-05       Impact factor: 3.494

4.  Serum level of the periostin, a homologue of an insect cell adhesion molecule, as a prognostic marker in nonsmall cell lung carcinomas.

Authors:  H Sasaki; M Dai; D Auclair; I Fukai; M Kiriyama; Y Yamakawa; Y Fujii; L B Chen
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

5.  Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma.

Authors:  Badar M Mian; Nishin Bhadkamkar; Joel W Slaton; Peter W T Pisters; Danai Daliani; David A Swanson; Louis L Pisters
Journal:  J Urol       Date:  2002-01       Impact factor: 7.450

6.  Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation.

Authors:  A Kruzynska-Frejtag; M Machnicki; R Rogers; R R Markwald; S J Conway
Journal:  Mech Dev       Date:  2001-05       Impact factor: 1.882

7.  Elevated serum periostin levels in patients with bone metastases from breast but not lung cancer.

Authors:  Hidefumi Sasaki; Chih-Yi Yu; Meiru Dai; Carmen Tam; Massimo Loda; Daniel Auclair; Lan Bo Chen; Anthony Elias
Journal:  Breast Cancer Res Treat       Date:  2003-02       Impact factor: 4.872

8.  Periostin secreted by epithelial ovarian carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5) integrins and promotes cell motility.

Authors:  Lindsay Gillan; Daniela Matei; David A Fishman; C S Gerbin; Beth Y Karlan; David D Chang
Journal:  Cancer Res       Date:  2002-09-15       Impact factor: 12.701

9.  Expression of the periostin mRNA level in neuroblastoma.

Authors:  Hidefumi Sasaki; Yoko Sato; Satoshi Kondo; Ichiro Fukai; Masanobu Kiriyama; Yosuke Yamakawa; Yoshitaka Fuji
Journal:  J Pediatr Surg       Date:  2002-09       Impact factor: 2.545

10.  Expression of Periostin, homologous with an insect cell adhesion molecule, as a prognostic marker in non-small cell lung cancers.

Authors:  H Sasaki; K M Lo; L B Chen; D Auclair; Y Nakashima; S Moriyama; I Fukai; C Tam; M Loda; Y Fujii
Journal:  Jpn J Cancer Res       Date:  2001-08
View more
  24 in total

Review 1.  Introductory review: periostin-gene and protein structure.

Authors:  Akira Kudo
Journal:  Cell Mol Life Sci       Date:  2017-09-07       Impact factor: 9.261

Review 2.  Periostin as a multifunctional modulator of the wound healing response.

Authors:  John T Walker; Karrington McLeod; Shawna Kim; Simon J Conway; Douglas W Hamilton
Journal:  Cell Tissue Res       Date:  2016-05-28       Impact factor: 5.249

Review 3.  Biomarkers in renal cancer.

Authors:  Holger Moch; John Srigley; Brett Delahunt; Rodolfo Montironi; Lars Egevad; Puay Hoon Tan
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

4.  Distinct expression pattern of periostin splice variants in chondrocytes and ligament progenitor cells.

Authors:  Lei Cai; Robert H Brophy; Eric D Tycksen; Xin Duan; Ryan M Nunley; Muhammad Farooq Rai
Journal:  FASEB J       Date:  2019-04-16       Impact factor: 5.191

5.  [Epithelial-mesenchymal transition in non-small cell lung cancer].

Authors:  A Soltermann
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 6.  Periostin expression and epithelial-mesenchymal transition in cancer: a review and an update.

Authors:  Laura Morra; Holger Moch
Journal:  Virchows Arch       Date:  2011-10-14       Impact factor: 4.064

7.  POSTN promotes proliferation and epithelial-mesenchymal transition in renal cell carcinoma through ILK/AKT/mTOR pathway.

Authors:  Yuan-Yuan Jia; Yue Yu; Hong-Jun Li
Journal:  J Cancer       Date:  2021-05-13       Impact factor: 4.207

8.  Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma.

Authors:  Stefanie Regine Dannenmann; Julia Thielicke; Martina Stöckli; Claudia Matter; Lotta von Boehmer; Virginia Cecconi; Thomas Hermanns; Lukas Hefermehl; Peter Schraml; Holger Moch; Alexander Knuth; Maries van den Broek
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

9.  RNA-directed epigenetic silencing of Periostin inhibits cell motility.

Authors:  Nicholas C Lister; Matthew Clemson; Kevin V Morris
Journal:  R Soc Open Sci       Date:  2015-06-09       Impact factor: 2.963

10.  Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease.

Authors:  Darren P Wallace; Corey White; Lyudmyla Savinkova; Emily Nivens; Gail A Reif; Cibele S Pinto; Archana Raman; Stephen C Parnell; Simon J Conway; Timothy A Fields
Journal:  Kidney Int       Date:  2013-11-27       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.